Trial Profile
A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (XL) (4mg once daily) with placebo in patients with symptoms of Urge Urinary Incontinence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Dec 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Tolterodine
- Indications Urge incontinence; Urinary incontinence
- Focus Registrational; Therapeutic Use
- 07 Dec 2012 New trial record